Chaturvedi A K, Canfield D V
Toxicology and Accident Research Laboratory, Federal Aviation Administration, U.S. Department of Transportation, Oklahoma City, OK, USA.
Aviat Space Environ Med. 1997 Mar;68(3):230-3.
In aviation accident investigations, specimens from fatal aircraft victims are analyzed for drugs. The presence of drugs suggests possible associated medical conditions for which they might have been taken. As drugs are mostly present in therapeutic to subtherapeutic levels in aviation forensic toxicology cases, determination of parent drugs and their metabolites in multispecimens is of significance. Although chemically reactive metabolites are difficult to detect, physiologically active and inactive metabolites can be analyzed. Selective and sensitive techniques are available, but unavailability of metabolite reference standards, endogenous substance interference, and low tissue metabolite levels limit the analyses. However, the majority of primary metabolites can be effectively characterized/quantitated. Demonstrating the presence of drug (e.g., terfenadine, cocaine, THC) metabolites provides a compelling evidence for exposure to the parent drug and facilitates interpretation of results, particularly when the metabolites are active. Such analyses are not as helpful if the metabolites are also available as drugs (e.g., diazepam, temazepam, oxazepam).
在航空事故调查中,会对遇难飞机乘客的样本进行药物分析。药物的存在表明可能存在与之相关的医疗状况,而服用药物可能正是为了治疗这些状况。在航空法医毒理学案例中,药物大多以治疗剂量至亚治疗剂量存在,因此在多个样本中测定母体药物及其代谢物具有重要意义。虽然化学反应性代谢物难以检测,但生理活性和非活性代谢物可以进行分析。有选择性且灵敏的技术可供使用,但代谢物参考标准品的缺乏、内源性物质的干扰以及组织中代谢物水平较低限制了分析。然而,大多数主要代谢物能够得到有效表征/定量。证明药物(如特非那定、可卡因、四氢大麻酚)代谢物的存在为接触母体药物提供了有力证据,并有助于结果的解读,尤其是当代谢物具有活性时。如果代谢物本身也是药物(如地西泮、替马西泮、奥沙西泮),那么此类分析的帮助就不大了。